Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study

Marc Rendell, Steven G. Chrysant

Research output: Contribution to journalArticle

9 Scopus citations

Fingerprint Dive into the research topics of 'Review of the safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.